Sponsored Projects Administration

Lung-MAP trial launched

Published July 08, 2014 by OSP


Between 500 and 1,000 patients will be screened per year for more than 200 cancer-related gene alterations. Based on the tumor profiles, all patients will then be assigned to one of five initial treatment arms, testing four investigational targeted treatments and an anti-PD-L1 immunotherapy.

Read More